ImmunityBio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- ImmunityBio Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IBRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001326110
Board of directors
-
Barry J. Simon · DirectorSince 2023
-
Bruce Wendel · DirectorSince 2025
-
Cheryl Cohen · DirectorSince 2023
-
Christobel Selecky · DirectorSince 2023
-
John Owen Brennan · DirectorSince 2023
-
Linda Maxwell · DirectorSince 2023
-
Michael D. Blaszyk · DirectorSince 2023
-
Patrick Soon-Shiong · Director · See remarksSince 2023
-
Richard Adcock · Director · CEO & PresidentSince 2023
-
Wesley Clark · DirectorSince 2021
Chief executives
Richard Adcock
· CEO & President
Dates unknown
Board connections
5 of this board's directors also sit on 5 other boards.
- via Wesley Clark
- via Cheryl Cohen
- via Bruce Wendel
- via Patrick Soon-Shiong
- via Linda Maxwell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $8,386,214
- 14 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Cheryl Cohen Director | Option exercise | +55,979 | $2.98 | $166,817 |
| Jul 2, 2026 | Cheryl Cohen Director | Open-market sale | −131,210 | $9.50 | $1,246,941 |
| Jul 1, 2026 | Christobel Selecky Director | Option exercise | +35,064 | $2.98 | $104,491 |
| Jul 1, 2026 | Christobel Selecky Director | Option exercise | +124,414 | $2.99 | $371,998 |
| Jul 1, 2026 | Christobel Selecky Director | Open-market sale | −159,478 | $9.02 | $1,439,066 |
| Jun 30, 2026 | Christobel Selecky Director | Option exercise | +700 | $2.98 | $2,086 |
| Jun 30, 2026 | Christobel Selecky Director | Option exercise | +300 | $2.99 | $897 |
| Jun 30, 2026 | Christobel Selecky Director | Open-market sale | −1,000 | $9.00 | $9,000 |
| Jun 29, 2026 | Christobel Selecky Director | Option exercise | +32,173 | $2.98 | $95,876 |
| Jun 29, 2026 | Christobel Selecky Director | Option exercise | +33,549 | $2.99 | $100,312 |
| Jun 29, 2026 | Christobel Selecky Director | Option exercise | +30,000 | $2.84 | $85,200 |
| Jun 29, 2026 | Christobel Selecky Director | Open-market sale | −95,722 | $9.01 | $862,216 |
| Jun 24, 2026 | Barry J. Simon Director | Open-market sale | −25,000 | $7.88 | $197,000 |
| Jun 4, 2026 | Barry J. Simon Director | Open-market sale | −23,033 | $7.18 | $165,377 |
| Mar 31, 2026 | Patrick Soon-Shiong Director, Officer (See remarks), 10% owner | Derivative conversion | +4,606,596 | $5.43 | $25,013,816 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.